Preview
Unable to display preview. Download preview PDF.
References
Abramova, A.A., and Grinberg, L.M. (1993). [Pathology of anthrax sepsis according to materials of the infectious outbreak in 1979 in Sverdlovsk (microscopic change s)] Arkh. Patol. 55:18–23 (in Russian).
Abramova, F.A., Grinberg, L.M., Yampolskaya, O.V., and Walker, D.H. (1993). Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc. Natl. Acad. Sci. U.S.A. 90:2291–2294.
ABS, a Subsidiary of Analex. (2004). Report to the Department of State, August.
Albrink, W., Brooks, S., Biron, R., and Kopel, M. (1960). Human inhalation anthrax: a report of three fatal cases. Am. J. Pathol. 36:457–468.
Albrink, W.S., and Goodlow, R.J. (1959). Experimental inhalation anthrax in chimpanzees. Am. J. Pathol. 35:1055–1065.
Alibek, K. (1999). Biohazard: The Chilling True Story of the Largest Covert Biological Weapons Program in the World — Told from Inside by the Man Who Ran It. Random House, New York, p. 74.
Barakat, L.A., Quentzel, H.L., Jernigan, J.A., Kirschke, D.L., Griffith, K., Spear, S.M., Kelley, K., Barden, D., Mayo, D., Stephens, D.S., Popovic, T., Marston, C., Zaki, S.R., Guarner, J., Shieh, W.J., Carver, H.W. 2nd, Meyer, R.F., Swerdlow, D.L., Mast, E.E., and Hadler, J.L. [Anthrax Bioterrorism Investigation Team]. (2002). Fatal inhalational anthrax in a 94-year-old Connecticut woman. J.A.M.A., 287(7):863–868.
Barnaby, W. (2000). The Plague Makers: The Secret World of Biological Weapons. Continuum, New York, 123.
Belluck, P. (2001). Anthrax Outbreak of’ 57 Felled a Mill but Yielded Answers. New York Times, October 27, 2001.
Bonventre, P.F., and Eckert, N.J. (1963). The biologic activities of Bacillus anthracis and Bacillus cereus culture filtrates. Am. J. Pathol. 43:201–211.
Bonventre, P.F., Sueoka, W., True, C.W., Klein, F., and Lincoln, R. (1967). Attempts to implicate the central nervous system as a primary site of action for Bacillus anthracis lethal toxin. Fed. Proc. 26:1549–1553.
Brachman, P., and Pagano, J. (1961). Two cases of fatal inhalation anthrax, one associated with sarcoidosis. N. Engl. J. Med. 265:203–208.
Brachman, P.S. (1980). Inhalation anthrax. Ann N.Y. Acad. Sci. 353:83–93.
Brook, I. (2002). The prophylaxis and treatment of anthrax. Int. J. Antimicrob. Agents 20(5):320–325 [review].
Brooksher, W., and Briggs, J. (1920). Pulmonary anthrax: report of a case. J.A.M.A. 74:323–324.
Bush, L.M., Abrams, B.H., Beall, A., and Johnson, C.C. (2001). Index case of fatal inhalational anthrax due to bioterrorism in the United States. N. Engl. J. Med. 345:1607–1610.
Carucci, J.A., McGovern, T.W., Norton, S.A., Daniel, C.R., Elewski, B.E., Fallon-Friedlander, S., Lushniak, B.D., Taylor, J.S., Warschaw, K., and Wheeland, R.G. (2002). Cutaneous anthrax management algorithm. J. Am. Acad. Dermatol. 47(5):766–769.
Carus, W.S. (2001). Bioterrorism and Biocrimes: The Illicit Use of Biological Agents Since 1900. Washington, D.C.: National Defense University Center for Counterproliferation Research, pp. 108–109.
CDC Emergency Preparedness and Response Website. (2001). Anthrax Q & A. http://www.bt.cdc.gov/agent/anthrax/faq/diagnosis.asp.
CDC Treatment Protocols for Cases of Inhalational and Cutaneous Anthrax Associated with Bioterrorist Attack Website. (2001). Anthrax Q & A. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5042a1.htm.
Chandramukhi, A., Shankar, P., Rao, T., Sundararajan, S., and Swamy, H.S. (1987). Acute leptomeningitis due to Bacillus anthracis. Trop. Geol. Med. 35:79–82.
CNN.com (2001). Anthrax through the ages. http://www.cnn.com/2001/HEALTH/conditions/10/16/anthrax.timeline/
Cole, S.T., Eiglmeier, K., Parkhill, J., James, K.D., Thomson, N.R., Wheeler, P.R., Honore, N., Garnier, T., Churcher, C., Harris, D., Mungall, K., Basham, D., Brown, D., Chillingworth, T., Connor, R., Davies, R.M., Devlin, K., Duthoy, S., Feltwell, T., Fraser, A., Hamlin, N., Holroyd, S., Hornsby, T., Jagels, K., Lacroix, C., Maclean, J., Moule, S., Murphy, L., Oliver, K., Quail, M.A., Rajandream, M.A., Rutherford, K.M., Rutter, S., Seeger, K., Simon, S., Simmonds, M., Skelton, J., Squares, R., Squares, S., Stevens, K., Taylor, K., Whitehead, S., Woodward, J.R., and Barrell, B.G. (2001). Massive gene decay in the leprosy bacillus. Nature 409:1007–1011.
Committee to Assess the Safety and Efficacy of the Anthrax Vaccine, Medical Follow-Up Agency. (2002). The Anthrax Vaccine: Is It Safe? Does It Work? Institute of Medicine, National Academy Press, Washington, D.C., http://www.iom.edu/iom/iomhome.nsf/WFiles/Anthrax-8-pager1FINAL/$file/Anthrax-8-pager1FINAL.pdf.
Cowdery, J. (1947). Primary pulmonary anthrax with septicemia. Arch. Pathol. 43:396–399.
Cranmer, H., and Martinez, M. (2003). CBRNE — anthrax infection. http://www.emedicine.com/emerg/topic864.htm/.
Dalldorf, F.G., and Beall, F.A. (1967). Capillary thrombosis as a cause of death in experimental anthrax. Arch. Pathol. 83:154–161.
Dixon, T.C., Fadl, A.A., Koehler, T.M., Swanson, J.A., and Hanna, P.C. (2000). Early Bacillus anthracismacrophage interactions: intracellular survival survival and escape. Cell Microbiol. 2:453–463.
Doganay, M., Almac, A., and Hanagasi, R. (1986). Primary throat anthrax. Scand. J. Infect. Dis. 18:415–419.
Drake, D.J., and Blair, A.W. (1971). Meningitic anthrax. Cent. Afr. J. Med. 17:97–98.
Dutz, W., and Kohout, E. (1971). Anthrax. Pathol. Annu. 6:209–248.
Enticknap, J.B., Galbraith, N.S., Tomlinson, A.J.H., and Elias-Jones, T.F. (1968). Pulmonary anthrax caused by contaminated sacks. Br. J. Industr. Med. 25:72–74.
Eremin, S.A., Nikiforov, A.K., Kostiukova, T.A., and Mikshis, N.I. (1999). The capacity of the causative agent of anthrax to reduce methylene blue. Zh. Mikrobiol. Epidemiol. Immunobiol. 4:91–92 (in Russian).
Erwin, J.L., DaSilva, L.M., Bavari, S., Little, S.F., Friedlander, A.M., and Chanh, T.C. (2001). Macrophage-derived cell lines do not express proinflammatory cytokines after exposure to Bacillus anthracis lethal toxin. Infect. Immun. 69:1175–1177.
Fellows, P., Linscott, M., Ivins, B., et al. (2001). Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin. Vaccine 19:3241–3247.
Fouet, A., Sirard, J.C., and Mock, M. (1994). Bacillus anthracis pXO1 virulence plasmid encodes a type 1 DNA topoisomerase. Mol. Microbiol. 11:471–479.
Friedlander, A.M. (1986). Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. J. Biol. Chem. 261:7123–7126.
Friedlander, A.M., Welkos, S.L., Pitt, M.L.M., Ezzell, J.W., Worsham, P.L., Rose, K.J., Ivins, B.E., Lowe, J.R., Howe, G.B., Mikesell, P., and Lawrence, W.B. (1993). Postexposure prophylaxis against experimental inhalation anthrax. J. Infect. Dis. 167:1239–1243.
Fukao, T. (2004). Immune system paralysis by anthrax lethal toxin: the roles of innate and adaptive immunity. Lancet Infect. Dis. 4:166–170 [review].
Gold, H. (1955). Anthrax: a report of one hundred seventeen cases. AMA Arch. Intern. Med. 96:387–396.
Goodman, J.W., and Nitecki, D.E. (1967). Studies on the relation of a prior immune response to immunogenicity. Immunology 13:577–583.
Gordon, V.M., Klimpel, K.R., Arora, N., Henderson, M.A., and Leppla, S.H. (1995). Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases. Infect. Immun. 63:82–87.
Greenwood, D., Slack, R., and Peutherer, J. (1997). Medical Microbiology. A Guide to Microbial Infections: Pathogenesis, Immunity, Laboratory Diagnosis and Control. Churchill Livingstone, New York.
Grinberg, L.M., Abramova, F.A., Yampolskaya, O.V., Walker, D.H., and Smith, J.H. (2001). Quantitative pathology of inhalational anthrax I: quantitative microscopic findings. Mod. Pathol. 14:482–495.
Guidi-Rontani, C., Levy, M., Ohayon, H., and Mock, M. (2001). Fate of germinated Bacillus anthracis spores in primary murine macrophages. Mol. Microbiol. 42:931–938 [erratum in Mol. Microbiol. 2002;44:297].
Guidi-Rontani, C., Pereira, Y., Ruffie, S., Sirard, J.C., Weber-Levy, M., and Mock, M. (1999). Identification and characterization of a germination operon on the virulence plasmid pXO1 of Bacillus anthracis. Mol. Microbiol. 33:407–414.
Guidi-Rontani C., Weber-Levy, M., Labruyère, E., and Mock, M. (1999). Germination of Bacillus anthracis spores within alveolar macrophages. Mol. Microbiol. 31:9–17.
Haight, T.H. (1952). Anthrax meningitis: review of literature and report of two cases with autopsies. Am. J. Med. Sci. 224:57–69.
Hail, A.S., Rossi, C.A., Ludwig, G.V., Ivins, B.E., Tammariello, R.F., and Henchal, E.A. (1999). Comparison of non-invasive sampling sites for early detection of Bacillus anthracis spores from rhesus monkeys after aerosol exposure. Mil. Med. 164:833–837.
Hanna, P.C., Kruskal, B.A., Ezekowitz, R.A., Bloom, B.R., and Collier, R.J. (1994). Role of macrophage oxidative burst in the action of anthrax lethal toxin. Mol. Med. 1:7–18.
Hansen, H.J., Norberg, B.K., and Schmiterloew, C.G. (1961). Pathophysiological studies on anthrax. Acta Pathol. Microbiol. Scand. 51(Suppl 144):307–308.
Heidelberg, J.F., Eisen, J.A., Nelson, W.C., Clayton, R.A., Gwinn, M.L., Dodson, R.J., Haft, D.H., Hickey, E.K., Peterson, J.D., Umayam, L., Gill, S.R., Nelson, K.E., Read, T.D., Tettelin, H., Richardson, D., Ermolaeva, M.D., Vamathevan, J., Bass, S., Qin, H., Dragoi, I., Sellers, P., McDonald, L., Utterback, T., Fleishmann, R.D., Nierman, W.C., and White, O. (2000). DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae. Nature 406:477–483.
Inglesby, T.V., O’Toole, T., Henderson, D.A., Bartlett, J.G., Ascher, M.S., Eitzen, E., Friedlander, A.M., Gerberding, J., Hauer, J., Hughes, J., McDade, J., Osterholm, M.T., Parker, G., Perl, T.M., Russell, T.K., and Tonat, K. (2002). Anthrax as a biological weapon, 2002: updated recommendations for management. J.A.M.A. 287:2236–2252 [review; erratum in J.A.M.A. 2002;288:1849].
Ivins, B.E., Fellows, P., and Pitt, M.L., et al. (1996). Efficacy of standard human anthrax vaccine against Bacillus anthracis aerosol spore challenge in rhesus monkeys. Salisbury Med. Bull. 87:125–126.
Jamie, W.E. (2002). Anthrax: diagnosis, treatment, prevention. Primary Care Update for OB/GYNs 9:117–121.
Jernigan, D.B., Raghunathan, P.L., Bell, B.P., Brechner, R., Bresnitz, E.A., Butler, J.C., Cetron, M., Cohen, M., Doyle, T., Fischer, M., Greene, C., Griffith, K.S., Guarner, J., Hadler, J.L., Hayslett, J.A., Meyer, R., Petersen, L.R., Phillips, M., Pinner, R., Popovic, T., Quinn, C.P., Peefhuis, J., Reissman, D., Rosenstein, N., Schuchat, A., Shieh, W.J., Siegal, L., Swerdlow, D.L., Tenover, F.C., Traegar, M., Ward, J.W., Weisfuse, I., Wiersma, S., Yeskey, K., Zaki, S., Ashford, D.A., Perkins, B.A., Ostroff, S., Hughes, J., Fleming, D., Koplan, J.P., Gerberding, and the National Anthrax Investigation Team. (2002). Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg. Infect. Dis. 8:1019–1028.
Jernigan, J.A., Stephens, D.S., Ashford, D.A., Omenaca, C., Topiel, M.S., Galbraith, M., Tapper, M., Fisk, T.L., Zaki, S., Popovic, T., Meyer, R.F., Quinn, C.P., Harper, S.A., Fridkin, S.K., Sejvar, J.J., Shepard, C.W., McConnell, M., Guarner, J., Shieh, W.J., Malecki, J.M., Gerberding, J.L., Hughes, J.M., Perkins, B.A., and members of the Anthrax Bioterrorism Investigation Team. (2001). Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg. Infect. Dis. 7:933–944.
Keim, P., Smith, K.L., Keys, C., Takahashi, H., Kurata, T., and Kaufmann, A. (2001). Molecular investigation of the Aum Shinrikyo anthrax release in Kameido, Japan. J. Clin. Microbiol. 39(12):4566–4567.
Klein, F., Hodges, D.R., Mahlandt, B.G., Jones, W.I., Haines, B.W., and Lincoln, R.E. (1962). Anthrax toxin: causative agent in the death of rhesus monkeys. Science. 138:1331–1333.
Klein, F., Walker, J.S., Fitzpatrick, D.F., Lincoln, R.E., Mahlandt, B.G., Jones, W.I. Jr, Dobbs J.P., and Hendrix, K.J. (1966). Pathophysiology of anthrax. J. Infect. Dis. 116:123–138.
Klichko, V.I., Miller, J., Wu, A., Popov, S.G., and Alibek, K. (2003). Anaerobic induction of Bacillus anthracis hemolytic activity. Biochem. Biophys. Res. Commun. 303:855–862.
Knights, E.M. (0000). Anthrax. History Magazine. Accessed online at: http://www.historymagazine.com/anthrax.html.
Koshi, G.M., Lalitha, D.J., Chacko, A., and Pulimood, B. (1981). Anthrax meningitis, a rare clinical entity. J Assoc. Phys. Ind. 29:59–62.
Kozel, T.R., Murphy, W.J., Brandt, S., Blazar, B.R., Lovchik, J.A., Thorkildson, P., Percival, A., and Lyons, C.R. (2004). mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia. Proc. Natl. Acad. Sci. U.S.A. 101:5042–5047
Krauss, F. (1943). Anthrax appearing primarily in the nose. Arch. Otolaryngol. 37:238–241.
LaForce, F.M., Bumford, F.H., Feeley, J.C., Stokes, S.L., and Snow, D.B. (1969). Epidemiologic study of a fatal case of inhalation anthrax. Arch. Environ. Health. 18:798–805.
Lindberg, A.A. (1999). Polyosides (encapsulated bacteria). C.R. Acad. Sci. 322:925–932.
Lindeque, P.M., and Turnbull, P.C. (1994). Ecology and epidemiology of anthrax in the Etosha National Park, Namibia. Onderstepoort J. Vet. Res. 61:71–83.
Little, S.F., and Ivins, B.E. (1999). Molecular pathogenesis of Bacillus anthracis infection. Microb. Infect. 2:131–139.
Litusov, N.V., Vasilyev, N.T., Vasilyev, P.G., and Burgasov, P.N. (2002). Pathomorphology of anthrax. Meditsina.
Liu, S., Schubert, R.L., Bugge, T.H., and Leppla, S.H. (2003). Anthrax toxin: structures, functions and tumour targeting. Expert Opin. Biol. Ther. 3:843–853 [review].
Macher, A. (2002). An industry-related outbreak of human anthrax, Massachusetts, 1868. Emerg. Infect. Dis. 8:1182.
Makino, S.I., Uchida, I., Terakado, N., Sasakawa, C., and Yoshikawa, M. (1989). Molecular characterization and protein analysis of the cap region, which is essential for encapsulation in Bacillus anthracis. J. Bacteriol. 171:722–730.
Mangold, T., and Goldberg, J. (1999). Plague Wars: The Terrifying Reality of Biological Warfare. St. Martins Griffin, New York, pp. 19–24.
Mesnage, S., Tosi-Couture, E., Gounon, P., Mock, M., and Fouet, A. (1998). The capsule and S-layer: two independent and yet compatible macromolecular structures in Bacillus anthracis. J. Bacteriol. 180:52–58.
Mikesell, P., Ivins, B.E., Ristroph, J.D., Vodkin, M.H., Dreier, T.M., and Leppla, S.H. (1983). Plasmids, Pasteur, and Anthrax. ASM News 49:320–322.
Milne, J.C., and Collier, R.J. (1993). pH-dependent permeabilization of the plasma membrane of mammalian cells by anthrax protective antigen. Mol. Microbiol. 10:647–653.
Milne, J.C., Furlong, D., Hanna, P.C., Wall, J.S., and Collier, R.J. (1994). Anthrax protective antigen forms oligomers during intoxication of mammalian cells. J. Biol. Chem. 269:20607–20612.
Moayeri, M., Haines, D., Young, H.A., and Leppla, S.H. (2003). Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice. J. Clin. Invest. 112:670–682.
Mock, M., and Mignot, T. (2003). Anthrax toxins and the host: a story of intimacy. Cell Microbiol. 5:15–23 [review].
Mogridge, J., Cunningham, K., and Collier, R.J. (2002). Stoichiometry of anthrax toxin complexes. Biochemistry 41:1079–1082.
Nobel Lectures, Physiology or Medicine 1901–1921, Elsevier Publishing Company, Amsterdam, 1967.
Norberg, B.K., Schmiterloew, C.G., Bergrahm, B., and Lundstroem, H. (1964). Further pathophysiological investigations into the terminal course of experimental anthrax in the rabbit. Acta. Pathol. Microbiol. Scand. 60:108–116.
Office of Public Health Service Historian — National Library of Medicine. (2001). A Brief History of Anthrax. http://lhncbs.nlm.nih.gov/apdb/phsHistory/resources/anthrax/anthrax02.html.
Ogata, H., Audic, S., Renesto-Audiffren, P., Fournier, P.E., Barbe, V., Samson, D., Roux, V., Cossart, P., Weissenbach, J., Claverie, J.M., and Raoult, D. (2001). Mechanisms of evolution in Rickettsia conorii and R. prowazekii. Science 293:2093–2098.
Okinaka, R.T., Cloud, K., Hampton, O., Hoffmaster, A.R., Hill, K.K., Keim, P., Koehler, T.M., Lamke, G., Kumano, S., Mahillon, J., Manter, D., Martinez, Y., Ricke, D., Svensson, R., and Jackson, P.J. (1999). Sequence and organization of pXO1, the large Bacillus anthracis plasmid harboring the anthrax toxin genes. J. Bacteriol. 181:6509–6515.
Pellizzari, R., Guidi-Rontani, C., Vitale, G., Mock, M., and Montecucco, C. (1999). Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha. FEBS Lett. 462:199–204.
Pile, J.C., Malone J.D., and Etizen, E.M., et al. (1998). Anthrax as a potential biological warfare agent. Arch. Intern. Med. 158:429–434.
Plotkin, S.A., Brachman, P.S., Utell, M., Bumford, F.H., and Atchison, M.M. (2002). An epidemic of inhalation anthrax, the first in the twentieth century: clinical features. Am. J. Med. 112:4–12.
Pluot, M., Vital, C., Aubertin, J., Croix, J.C., Pire, J.C., and Poisot D. (1976). Anthrax meningitis: report of two cases with autopsies. Acta Neuropathol. 36:339–345.
Popov, S.G., Villasmil, R., Bernardi, J., Grene, E., Cardwell, J., Popova, T., Wu, A., Alibek, D., Bailey, C., and Alibek, K. (2002a). Effect of Bacillus anthracis lethal toxin on human peripheral blood mononuclear cells. FEBS Lett. 527:211–215.
Popov, S.G., Villasmil, R., Bernardi, J., Grene, E., Cardwell, J., Wu, A., Alibek, D., Bailey, C., and Alibek, K. (2002b). Lethal toxin of Bacillus anthracis causes apoptosis of macrophages. Biochem. Biophys. Res. Commun. 293:349–55.
Ramachandran, S., and Natarajan, M. (1968). Tissue response to experimental anthrax of sheep and goats. Indian Vet. J. 45:381–387.
Rangel, R.A., and Gonzalez, D.A. (1975). Bacillus anthracis meningitis. Neurology 25:525–530.
Ray, K.C., Mesnage, S., Washburn, R., Mock, M., Fouet, A., and Blaser, M. (1998). Complement binding to Bacillus anthracis mutants lacking surface structures. Presented at the 98th Annual ASM General Meeting, Atlanta, Georgia.
Read, T.D., Peterson, S.N., Tourasse, N., Baillie, L.W., Paulsen, I.T., Nelson, K.E., Tettelin, H., Fouts, D.E., Eisen, J.A., Gill, S.R., Holtzapple, E.K., Okstad, O.A., Helgason, E., Rilstone, J., Wu, M., Kolonay, J.F., Beanan, M.J., Dodson, R.J., Brinkac, L.M., Gwinn, M., DeBoy, R.T., Madpu, R., Daugherty, S.C., Durkin, A.S., Haft, D.H., Nelson, W.C., Peterson, J.D., Pop, M., Khouri, H.M., Radune, D., Benton, J.L., Mahamoud, Y., Jiang, L., Hance, I.R., Weidman, J.F., Berry, K.J., Plaut, R.D., Wolf, A.M., Watkins, K.L., Nierman, W.C., Hazen, A., Cline, R., Redmond, C., Thwaite, J.E., White, O., Salzberg, S.L., Thomason, B., Friedlander, A.M., Koehler, T.M., Hanna, P.C., Kolsto, A.B., and Fraser, C.M. (2003). The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria. Nature 423:81–86.
Record, B.R., and Wallis, R.G. (1956). Physicochemical examination of polyglutamic acid from Bacillus anthracis grown in vivo. Biochem. J. 63:443–447.
Ross, J.M. (1957). The pathogenesis of anthrax following the administration of spores by the respiratory route. J. Pathol. Bacteriol. 73:485–494.
Roux, V., Bergoin, M., Lamaze, N., and Raoult, D. (1997). Reassessment of the taxonomic position of Rickettsiella grylli. Int. J. Syst. Bacteriol. 47:1255–1257.
Rozen’er, L.A. (1948). Anthrax in Humans. State publisher, Moldova, Kishinev.
Severn, M. (1976). A fatal case of pulmonary anthrax. Br. Med. J. 27:748.
Shapiro, L.B., and Galinobskoi, C.E. (1923). Anthrax case via inhalation. clin. med. 4:13–14.
Smith, H., Keppie, J., and Stanley, J.L. (1955). The chemical basis of the virulence of B. Anthracis. Br. J. Exp. Pathol. 36:460–472.
Smith, H., and Stoner, H.B. (1967). Anthrax toxic complex. Fed Proc. 26:1554–1557.
Stephens, R.S., Kalman, S., Lammel, C., Fan, J., Marathe, R., Aravind, L., Mitchell, W., Olinger, L., Tatusov, R.L., Zhao, Q., Koonin, E.V., and Davis, R.W. (1998). Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282:754–759.
Suffin, S. (1978). Inhalation anthrax in a home craftsman. Human Pathol. 9:594–597.
Swartz, M.N. (2001). Recognition and management of anthrax—an update. N. Engl. J. Med. 345(22):1621–1626.
Teacher, J.H., and Glasg, M.D. (1906). Primary intestinal anthrax in man; septicemia; haemorrhagic lepto-meningitis. Lancet 12:1306–1311.
Thorne, C.B. (1993). Bacillus anthracis. In: Sonenshein, A.L., Hoch, J.A., and Losick, R. (eds.), Bacillus subtilis and Other Gram-positive Bacteria. Washington, D.C., ASM, pp. 113–124.
Vessal, K. (1975). Radiological changes in inhalational anthrax. A report of radiological and patological corellations in two cases. Clin. Radiol. 26:471–474.
Vitale, G., Pellizzari, R., Recchi, C., Napolitani, G., Mock, M., and Montecucco, C. (1998). Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. Biochem. Biophys. Res. Commun. 248:706–711.
Walker, J.S., Lincoln, R.E., and Klein, F. (1967). Pathophysiological and biochemical changes in anthrax. Fed Proc. 26:1539–1544.
Wang, T.T., Fellows, P.F., Leighton, T.J., and Lucas, A.H. (2004). Induction of opsonic antibodies to the gamma-D-glutamic acid capsule of Bacillus anthracis by immunization with a synthetic peptidecarrier protein conjugate. FEMS Immunol. Med. Microbiol. 40:231–237.
Welkos, S.L., Keener, T.J., and Gibbs, P.H. (1986). Differences in susceptibility of inbred mice to Bacillus anthracis. Infect. Immun. 51:795–800.
WHO Model G for PCR detection of Bacillus anthracis, Standard Operating Procedure. WHO Website. (2004). http://w3.whosea.org/bct/anthrax/modelgf.htm.
Witkowski, J.A. (2002). The story of anthrax from antiquity to present: a biological weapon of nature and humans. Clin. Dermatol. 20:336–242.
Zaucha, G.M., Pitt, L.M., Estep, J., Ivins, B.E., and Friedlander, A.M. (1998). The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation. Arch. Pathol. Lab. Med. 122:982–992.
Zimmerman, B.E., and Zimmerman, D.J. (2003). Killer Germs: Microbes and Diseases that Threaten Humanity. Contemporary Books, New York, p. 219.
Zwartouw, H.T., and Smith, H. (1956). Polyglutamic acid from Bacillus anthracis grown in vivo: structure and aggressin activity. Biochem. J. 63:437–454.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Alibek, K., Lobanova, C., Popov, S. (2005). Anthrax: A Disease and a Weapon. In: Fong, I.W., Alibek, K. (eds) Bioterrorism and Infectious Agents: A New Dilemma for the 21st Century. Emerging Infectious Diseases of the 21st Century. Springer, Boston, MA. https://doi.org/10.1007/0-387-23685-6_1
Download citation
DOI: https://doi.org/10.1007/0-387-23685-6_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-23684-1
Online ISBN: 978-0-387-23685-8
eBook Packages: MedicineMedicine (R0)